Home
>
National Drug Code (NDC)
>
CLOZAPINE
CLOZAPINE - 57664-345-88 - (CLOZAPINE)
Drug Information of CLOZAPINE
| Product NDC: | 57664-345 |
| Proprietary Name: | CLOZAPINE |
| Non Proprietary Name: | CLOZAPINE |
| Active Ingredient(s): | 25 mg/1 & nbsp; CLOZAPINE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of CLOZAPINE
| Product NDC: | 57664-345 |
| Labeler Name: | Caraco Pharmaceutical Laboratories, Ltd. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075713 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20021115 |
Package Information of CLOZAPINE
| Package NDC: | 57664-345-88 |
| Package Description: | 100 TABLET in 1 BOTTLE (57664-345-88) |
NDC Information of CLOZAPINE
| NDC Code | 57664-345-88 |
| Proprietary Name | CLOZAPINE |
| Package Description | 100 TABLET in 1 BOTTLE (57664-345-88) |
| Product NDC | 57664-345 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | CLOZAPINE |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20021115 |
| Marketing Category Name | ANDA |
| Labeler Name | Caraco Pharmaceutical Laboratories, Ltd. |
| Substance Name | CLOZAPINE |
| Strength Number | 25 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Atypical Antipsychotic [EPC] |
